Cargando…

Lung microbiology and exacerbations in COPD

Chronic obstructive pulmonary disease (COPD) is the most common chronic respiratory condition in adults and is characterized by progressive airflow limitation that is not fully reversible. The main etiological agents linked with COPD are cigarette smoking and biomass exposure but respiratory infecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beasley, Victoria, Joshi, Priya V, Singanayagam, Aran, Molyneaux, Philip L, Johnston, Sebastian L, Mallia, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437812/ https://www.ncbi.nlm.nih.gov/pubmed/22969296 http://dx.doi.org/10.2147/COPD.S28286

Ejemplares similares

Viruses exacerbating chronic pulmonary disease: the role of immune modulation
por: Singanayagam, Aran, et al.
Publicado: (2012)

Models of infection and exacerbations in COPD
por: Papi, Alberto, et al.
Publicado: (2007)

Antiviral immunity is impaired in COPD patients with frequent exacerbations
por: Singanayagam, Aran, et al.
Publicado: (2019)

Influenza infection and COPD
por: Mallia, Patrick, et al.
Publicado: (2007)

A short-term mouse model that reproduces the immunopathological features of rhinovirus-induced exacerbation of COPD
por: Singanayagam, Aran, et al.
Publicado: (2015)

Inflammation and infections in unreported chronic obstructive pulmonary disease exacerbations
por: Calderazzo, Maria Adelaide, et al.
Publicado: (2019)

Asthma and viruses: A focus on rhinoviruses and SARS-CoV-2
por: Padayachee, Yorissa, et al.
Publicado: (2021)

How Viral Infections Cause Exacerbation of Airway Diseases
por: Mallia, Patrick, et al.
Publicado: (2006)

Asthma exacerbations: Origin, effect, and prevention
por: Jackson, David J., et al.
Publicado: (2011)

Pathophysiology of viral-induced exacerbations of COPD
por: Alfredo, Potena, et al.
Publicado: (2007)

Airway mucins promote immunopathology in virus-exacerbated chronic obstructive pulmonary disease
por: Singanayagam, Aran, et al.
Publicado: (2022)

Lower airway colonization and inflammatory response in COPD: a focus on Haemophilus influenzae
por: Finney, Lydia J, et al.
Publicado: (2014)

Experimental rhinovirus infection in COPD: Implications for antiviral therapies
por: Gunawardana, Natasha, et al.
Publicado: (2014)

Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations
por: Singanayagam, Aran, et al.
Publicado: (2018)

In vivo experimental models of infection and disease
por: Girkin, Jason, et al.
Publicado: (2019)

Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon
por: Finney, Lydia J., et al.
Publicado: (2021)

Exacerbations of COPD
por: Pavord, Ian D, et al.
Publicado: (2016)

Oxidative and Nitrosative Stress and Histone Deacetylase-2 Activity in Exacerbations of COPD
por: Footitt, Joseph, et al.
Publicado: (2016)

Consolidation and Exacerbation of COPD
por: Hurst, John R.
Publicado: (2018)

An experimental model of rhinovirus induced chronic obstructive pulmonary disease exacerbations: a pilot study
por: Mallia, Patrick, et al.
Publicado: (2006)

Acute exacerbation of COPD: is it the “stroke of the lungs”?
por: Hillas, Georgios, et al.
Publicado: (2016)

The contribution of infection and the respiratory microbiome in acute exacerbations of idiopathic pulmonary fibrosis
por: Invernizzi, Rachele, et al.
Publicado: (2019)

The prevalence and assessment of pain and dyspnoea in acute exacerbations of COPD: A systematic review
por: Clarke, Stephanie Y, et al.
Publicado: (2022)

Repurposing Existing Drugs for the Treatment of COVID-19
por: Farne, Hugo, et al.
Publicado: (2020)

β-blockers in exacerbations of COPD: feasibility of a randomised controlled trial
por: Chang, Catherina L., et al.
Publicado: (2017)

Acute exacerbations of chronic obstructive pulmonary disease: in search of diagnostic biomarkers and treatable traits
por: Mathioudakis, Alexander G, et al.
Publicado: (2020)

Haematological and Inflammatory Biomarkers Among Stable COPD and Acute Exacerbations of COPD Patients
por: Ramya, Priya A., et al.
Publicado: (2023)

Association between COPD exacerbations and lung function decline during maintenance therapy
por: Kerkhof, Marjan, et al.
Publicado: (2020)

Exacerbations of COPD
por: Viniol, Christian, et al.
Publicado: (2018)

Non-invasive ventilation in exacerbations of COPD
por: Ambrosino, Nicolino, et al.
Publicado: (2007)

Strategies for improving outcomes of COPD exacerbations
por: Wilkinson, Tom, et al.
Publicado: (2006)

Optimizing bronchodilation in the prevention of COPD exacerbations
por: Miravitlles, Marc, et al.
Publicado: (2017)

Th17 profile in COPD exacerbations
por: Ponce-Gallegos, Marco Antonio, et al.
Publicado: (2017)

COPD exacerbations: defining their cause and prevention
por: Wedzicha, Jadwiga A, et al.
Publicado: (2007)

Towards precision in defining COPD exacerbations
por: Jenkins, Christine R.
Publicado: (2021)

Prediction models for exacerbations in patients with COPD
por: Guerra, Beniamino, et al.
Publicado: (2017)

Colds as predictors of the onset and severity of COPD exacerbations
por: Johnston, Neil W, et al.
Publicado: (2017)

Association between lung function and exacerbation frequency in patients with COPD
por: Hoogendoorn, Martine, et al.
Publicado: (2010)

Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis
por: Mathioudakis, Alexander G., et al.
Publicado: (2017)

The Long-Term Burden of COPD Exacerbations During Maintenance Therapy and Lung Function Decline
por: Kerkhof, Marjan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5c5j61l8goe9rb9qb49o4v5n38